Trial Profile
Lamivudine plus adefovir or telbivudine plus adefovir for chronic hepatitis B patients with suboptimal response to adefovir.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2011
Price :
$35
*
At a glance
- Drugs Adefovir (Primary) ; Lamivudine (Primary) ; Telbivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 05 Sep 2011 New trial record